Lgd 4033 cancer
Cardarine stimulates fatty acid oxidation by reducing the utilization of glucose, thus shifting energy metabolism; meaning the body will use fat stores as a primary energy source. This causes a decrease in both subcutaneous and visceral fat mass in users, producing a leaner and more defined appearance. Decreases in visceral fat are desirable for users wanting to maintain a small waist; with high levels of visceral fat causing a protruding look to the stomach. Cardarine's lipolytic effects are similar to certain SARMs used for cutting, such as ostarine, lgd 4033 cancer. Anecdotal evidence suggests cardarine's fat-burning properties are more potent than its ability to build lean muscle tissue. In fact, according to studies, Cardarine, as well as other PPAR Delta receptor agonists, may lower blood lipids and prevent cardiovascular damage, lgd 4033 cancer.